Filtered by category: Quality Forum Clear Filter

Quality Forum Review: Barriers to Care: A Pharmacy-Based Pre-Exposure Prophylaxis (PrEP) Model

The PQA Quality Forum Webinar is a regular, recurring series on healthcare quality topics with a focus on medication use and medication services. It is a forum for educating and engaging with PQA members and quality-focused healthcare professionals.

Read More

Quality Forum Review: Prioritizing Pharmacy Measure Concepts for Value-Based Agreements

The PQA Quality Forum Webinar is a recurring series on healthcare quality topics which focus on medication use and medication services. The quality forum creates an opportunity for education and engagement with PQA members and quality-focused healthcare professionals.

Read More

The Patient Voice in Medication Therapy Management

The PQA Quality Forum Webinar is a recurring series on healthcare quality topics which focus on medication use and medication services. The quality forum creates an opportunity for education and engagement with PQA members and quality-focused healthcare professionals.

Read More

Quality Forum Review: Implementing Sustainable SDOH Programs in Community Pharmacies

The PQA Quality Forum Webinar is a regular, recurring series on healthcare quality topics with a focus on medication use and medication services. It is a forum for educating and engaging with PQA members and quality-focused healthcare professionals.

PQA’s April 22, 2021, Quality Forum welcomed a panel of experts to discuss implementation of sustainable social determinants of health (SDOH) programs in community pharmacies. Initial efforts have been promising, and presenters noted the need for more research, specifically in reimbursement.

David Jacobs, PharmD, PhD, an assistant professor in the Department of Pharmacy Practice at the University of Buffalo, began the conversation by defining SDOH in community pharmacy.

Jacobs said SDOH are non-medical factors that influence health outcomes and is defined by the World Health Organization as “conditions in which people are born, grow, work, live, and age.” The five categories of SDOH are:





Read More

Quality Forum Review: Best Practices to Support Tapering Patients on Long-Term Opioid Therapy

The PQA Quality Forum Webinar is a regular, recurring series on healthcare quality topics with a focus on medication use and medication services. It is a forum for educating and engaging with PQA members and quality-focused healthcare professionals.

PQA’s January 21, 2021, Quality Forum welcomed a panel of experts to discuss best practices to support tapering patients on long-term opioid therapy (LOT) for chronic non-cancer pain (CNCP) in out-patient settings. While the presenters noted more research is needed on the long-term benefits and side effects of opioid tapering, the results thus far have been promising.

Aisha Salman, MPH, a Program Officer at the National Academy of Medicine (NAM), began the conversation with an overview of the organization’s Action Collaborative on Countering the U.S. Opioid Epidemic.

Salman noted the severity of the opioid crisis in the U.S. Over 130 Americans die from an overdose every day, and 2.1 million people suffer from opioid use disorder. The opioid crisis cost $2.5 trillion between 2015 and 2018, and costs have been rapidly rising due to COVID-19.

In response, the NAM Action Collaborative seeks to apply a portfolio approach to address the epidemic, recognizing that no single policy will be enough. Established in 2018, the Action Collaborative is a public-private partnership with more than 60 participating members. The goal is facilitating a cohesive, systems response to the opioid crisis.

“We accomplish more when we work together,” Salman said. “It illustrates the necessity for a systems response to address a public health crisis like the opioid epidemic and underscores the important role that the Action Collaborative plays within this ecosystem.”

The Action Collaborative has four focus areas, each with a designated working group:











Read More